trending Market Intelligence /marketintelligence/en/news-insights/trending/r0ahhbt1fpphovdvb-sdtg2 content esgSubNav
In This List

Verrica Pharmaceuticals prices $75M IPO

Blog

2021 Year in Review: Highlighting Key Investment Banking Trends

Blog

Insight Weekly: US stock performance; banks' M&A risk; COVID-19 vaccine makers' earnings

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond


Verrica Pharmaceuticals prices $75M IPO

Verrica Pharmaceuticals Inc. priced its IPO of 5 million common shares at $15 apiece to raise gross proceeds of about $75 million.

The company has also granted the underwriters an option to buy up to an additional 750,000 shares.

Verrica said the shares are scheduled to start trading on the Nasdaq Global Market on June 15 under the ticker symbol VRCA.

The offering is expected to close June 19.

Bank of America Merrill Lynch, Jefferies and Cowen are serving as joint book-running managers for the offering.